Literature DB >> 17254779

Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.

Hubert Maehr1, Milan Uskokovic, Luciano Adorini, Giuseppe Penna, Roberto Mariani, Paola Panina, Nadia Passini, Elisa Bono, Silvia Perego, Mauro Biffi, Michael Holick, Catherine Spina, Nanjoo Suh.   

Abstract

The searches for drugs that exhibit antineoplastic activity and regulate blood pressure are among the most prevalent and compelling research activities today. Amazingly, there is ample precedence for the antiproliferative action of vitamin-D-related compounds and their role as endocrine suppressors of renin biosynthesis. We have recently synthesized a number of novel calcitriol analogs of the gemini family and originally selected for further studies an epimeric pair related to 19-nor-calcitriol whose 21-methyl group was replaced by a 5,5,5-trifluoro-4-hydroxy-4-(trifluoromethyl)-2-pentynyl group. While maintaining the acceptable calcemic responses, the IC50 concentrations of interferon-gamma release were reduced and the antiproliferative activity and inhibition of renin mRNA expression enhanced. Replacing the geminal methyl groups on the calcitriol-related side chain of these gemini compounds with trideuteriomethyl moieties further boosted the potency in the colon cancer model in mice some 10-fold, reduced NMU-induced breast cancer carcinogenesis in rats and decreased the IC(50) values for renin mRNA inhibition into the pM range.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254779     DOI: 10.1016/j.jsbmb.2006.12.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.

Authors:  Tiphaine Huet; Hubert Maehr; Hong Jin Lee; Milan R Uskokovic; Nanjoo Suh; Dino Moras; Natacha Rochel
Journal:  Medchemcomm       Date:  2011       Impact factor: 3.597

2.  20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Zorica Janjetovic; Robert C Tuckey; Radoslaw Bieniek; Junming Yue; Wei Li; Jianjun Chen; Minh N Nguyen; Edith K Y Tang; Duane Miller; Tai C Chen; Michael Holick
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-15       Impact factor: 4.249

3.  Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling.

Authors:  Hong Jin Lee; Jae-Young So; Andrew DeCastro; Amanda Smolarek; Shiby Paul; Hubert Maehr; Milan Uskokovic; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

4.  HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.

Authors:  Jae Young So; Joseph Wahler; Soumyasri Das Gupta; David M Salerno; Hubert Maehr; Milan Uskokovic; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2014-12-23       Impact factor: 4.292

5.  Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.

Authors:  Ayelet Shabtay; Hagar Sharabani; Zeev Barvish; Michael Kafka; Doron Amichay; Joseph Levy; Yoav Sharoni; Milan R Uskokovic; George P Studzinski; Michael Danilenko
Journal:  Oncology       Date:  2008-10-14       Impact factor: 2.935

6.  Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells.

Authors:  Edward Garay; Pawel Jankowski; Paulo Lizano; Stanislaw Marczak; Hubert Maehr; Luciano Adorini; Milan R Uskokovic; George P Studzinski
Journal:  Bioorg Med Chem       Date:  2007-04-25       Impact factor: 3.641

7.  Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.

Authors:  Hong Jin Lee; Shiby Paul; Nadi Atalla; Paul E Thomas; Xinjie Lin; Ill Yang; Brian Buckley; Gang Lu; Xi Zheng; You-Rong Lou; Allan H Conney; Hubert Maehr; Luciano Adorini; Milan Uskokovic; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

8.  Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation.

Authors:  Hubert Maehr; Hong Jin Lee; Bradford Perry; Nanjoo Suh; Milan R Uskokovic
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.